Labshake search
Citations for R&D Systems :
251 - 300 of 3762 citations for 5 1 3 benzothiazol 2 ylamino pentanoic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2023Quote: ... Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA or Human CXCL10/IP-10 DuoSet ELISA reagents (biotechne R&D systems) according to the manufacturer’s instructions.
-
bioRxiv - Immunology 2020Quote: ... and 1 μg/ml CD40-ligand-HA with 5 ng/ml anti-HA antibodies (R&D Systems, Minneapolis, USA), and separately in combination with IL-4 and IL-21 (100 IU each) ...
-
bioRxiv - Cell Biology 2023Quote: ... ascorbic acid and 40 ng/ml bFGF and VEGF (R&D Systems, MN). For single-cell RNA-seq ...
-
bioRxiv - Cell Biology 2024Quote: ... cells were seeded at 1.5×105/ml in primary differentiation medium supplemented with 1ng/ml interleukin-3 (IL-3, R&D Systems), 10ng/ml SCF and 1μg/ml doxycycline ...
-
bioRxiv - Immunology 2021Quote: ... and 2 ng/ml IL-2 (carrier-free; Tocris R&D Systems). Cells treated with only these functioned as the mock control ...
-
bioRxiv - Immunology 2024Quote: ... CXCL-2 (Mouse CXCL2/MIP-2 DuoSet ELISA, DY452, R&D Systems), myeloperoxidase (MPO ...
-
bioRxiv - Developmental Biology 2022Quote: ... 1 mM sodium pyruvate and 0.1 mM 2-mercaptoethanol) containing 50 ng/ml of ACTA (R&D Systems), 3 μM CHIR99021 (Tocris Bioscience ...
-
bioRxiv - Cell Biology 2020Quote: ... to RAW264.7 or 2 ng/mL transforming growth factor β-1(240-B/CF, R&D System, USA) to THP-1 for 24-36 hours ...
-
bioRxiv - Cancer Biology 2022Quote: ... Control or shLATS1/2 cells were counted and resuspended in 1% methylcellulose medium (R&D system Cat. # HSC001) prepared in complete growth medium ...
-
bioRxiv - Bioengineering 2020Quote: ... Levels of hIFN-λ1 were evaluated by human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA (DY1598B, R&D Systems, USA), according to manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2021Quote: ... HTM cells were cultured in serum-free DMEM with 1% PSG and subjected to the different treatments for 3 d: TGFβ2 (2.5 ng/ml; R&D Systems, Minneapolis, MN, USA), the ERK inhibitor U0126 (10 μM ...
-
bioRxiv - Microbiology 2021Quote: ... Cleaved caspase-3 was immunostained by incubating HAE with a primary human cleaved caspase-3 (Asp175) antibody (catalog no. MAB835; R&D Systems, Minneapolis ...
-
bioRxiv - Immunology 2022Quote: ... and 1 μg/ml CD40-ligand-HA with 5 ng/ml anti-HA antibodies (both R&D Systems, Minneapolis, USA), and Type B CpG OND D-SL01 (InvivoGen ...
-
bioRxiv - Cell Biology 2020Quote: ... and the mouse chemoattractant macrophage-inflammatory protein-2 (MIP-2, R&D Systems). Migration of cells was evaluated by trypan blue exclusion following incubation.
-
bioRxiv - Cancer Biology 2022Quote: ... 2 μg/mL Fibulin-2 (Cat no. 9559-FB-050, R&D Systems) coated ...
-
bioRxiv - Microbiology 2021Quote: ... and IGFBP-3 DuoSet ELISA kit (R&D Systems), respectively ...
-
bioRxiv - Developmental Biology 2020Quote: ... Rabbit α-Active Caspase-3 (R&D Systems, #AF835), Mouse α-PAX7 (DSHB) ...
-
bioRxiv - Developmental Biology 2020Quote: ... supplemented with BMP4 (3 ng/ml, R&D Systems) and Thiazovivin (2 μM ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 3 μM GSK3 inhibitor (R&D Systems, CHIR99021). mESC medium was made from Knockout DMEM (Gibco 10829018) ...
-
bioRxiv - Immunology 2020Quote: ... LAG-3 (Polyclonal, R&D Systems, Minneapolis, MN, USA), CD123 (clone 7G3) ...
-
bioRxiv - Bioengineering 2021Quote: ... 20ng/mL IL-3 (R&D Systems 203-IL), 20 ng/mL G-CSF (R&D Systems 214-CS) ...
-
bioRxiv - Bioengineering 2021Quote: ... 0.01µg/mL IL-3 (R&D Systems, 203-IL) and 0.005µg/mL TNFα (R&D Systems ...
-
bioRxiv - Cell Biology 2021Quote: ... with 20 ng/ml rmIL-3 (R&D Systems), 50 ng/ml Flt3-Ligand (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-cleaved caspase 3 were from R&D Systems.
-
bioRxiv - Neuroscience 2023Quote: ... 10ng/mL NT-3 (R&D Systems 267-N3), 100 ng/mL IGF (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... 10ng/mL NT-3 (R&D Systems 267-N3), 100 ng/mL IGF (R&D Systems ...
-
bioRxiv - Developmental Biology 2022Quote: ... 3 ng/ml rhBMP4 (R&D Systems, #314-BP), and 3 ng/ml rmWNT3a (R&D Systems ...
-
bioRxiv - Bioengineering 2023Quote: ... 8 μM GSK-3 inhibitor CHIR99021 (R&D Systems), 200 ng/ml fibroblast growth factor 9 (FGF9 ...
-
bioRxiv - Neuroscience 2024Quote: ... and 25 ng/ml rhIL-3 (R&D Systems). Macrophage precursor cells could be routinely harvested from dishes containing EBs every 6/7 days for up to 3/4 months ...
-
bioRxiv - Bioengineering 2023Quote: ... staining for anti-murine Fatty acid binding protein 4 (Fabp4) (R&D Systems, AF1443) was used ...
-
bioRxiv - Developmental Biology 2021Quote: ... 5 nM BMP4 (R&D systems), 1 μg/mL doxycycline (Sigma-Aldrich)) ...
-
bioRxiv - Cell Biology 2020Quote: ... Autophagy was induced by treating the cells for 2 hours in 250nM Torin-1 (R&D Systems, 4247/10) in 1X Hanks’ Balanced salt solution ...
-
bioRxiv - Cancer Biology 2023Quote: ... in 2% BSA/PBS solution and the appropriate fluorescently-conjugated secondary antibody (R&D Systems catalog #NL006, 1:200). Coverslips were mounted onto slide with DAPI-containing ProLong Gold media ...
-
bioRxiv - Physiology 2024Quote: ... The primary antibodies were MyBP-HL [2] and Contactin-2 (R&D Systems AF4439). Secondaries were Alexa Fluor Donkey anti-Rabbit 568 (Thermo Fisher A-10042 ...
-
bioRxiv - Neuroscience 2023Quote: ... for 5 min each time and subsequently incubated with blocking buffer (5% goat serum [R&D Systems, Minneapolis ...
-
bioRxiv - Cell Biology 2020Quote: ... media was supplemented with 5 ng/mL recombinant human TGFβ-1 (R&D Systems; resuspended in 4 mM HCl, 0.1% BSA).
-
bioRxiv - Neuroscience 2020Quote: ... OPCs were treated with LCN2 (1, 2.5, 5, 10, 20, 40, 80, or 160 ng/ml, R&D Systems, Shanghai, China) or vehicle control (0.0002% BSA ...
-
bioRxiv - Cell Biology 2021Quote: ... media was supplemented with 5 ng/mL recombinant human TGFβ-1 (R&D Systems; resuspended in 4 mM HCl, 0.1% BSA). MCF7 ...
-
bioRxiv - Immunology 2021Quote: ... PIGF-2 (R&D systems) and Endoglin/CD105 (R&D systems ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2-APB (R&D Systems), SKF96365 (Wako) ...
-
bioRxiv - Cancer Biology 2023Quote: ... Type 2 (R&D Systems) and plated on 8-chamber slides (Thermo Scientific).
-
bioRxiv - Immunology 2022Quote: ... Lipocalin-2 (R&D Systems) and high sensitivity TNF (Invitrogen ...
-
bioRxiv - Immunology 2024Quote: ... Type 2 (R&D Systems). 37.5μL of matrix was pipetted in the center of each well of an 8-chamber slide (Thermo Scientific ...
-
bioRxiv - Cancer Biology 2022Quote: ... miniloci in an endogenous IgH and Igκ knockout background (19,20) were immunized with recombinant human LAG-3–Fc protein (hLAG-3–hFc) (R&D Systems, Minneapolis, MN, USA), consisting of the extracellular domain of LAG-3 (Leu23-Leu450 ...
-
bioRxiv - Cell Biology 2020Quote: ... citric acid antigen retrieval was performed prior to immunohistochemistry for GATA4 (R&D Systems, AF2606). Staining was visualized using R.T.U ...
-
bioRxiv - Immunology 2020Quote: ... CA) with 1% human serum and 1,200 IU/ml of recombinant human interleukin-2 (R&D Systems, Inc., Minneapolis, MN). As a positive control ...
-
bioRxiv - Microbiology 2022Quote: ... and a mouse anti-SARS-CoV-2 N monoclonal antibody (clone 1035111, R&D Systems, Cat# MAB10474-SP, 1:400) was used as a primary antibody ...
-
bioRxiv - Microbiology 2022Quote: ... and a mouse anti-SARS-CoV-2 N monoclonal antibody (clone 1035111, R&D Systems, Cat# MAB10474-SP, 1:400) was used as a primary antibody ...
-
bioRxiv - Microbiology 2023Quote: ... and a mouse anti-SARS-CoV-2 N monoclonal antibody (clone 1035111, R&D Systems, Cat# MAB10474-SP, 1:400) was used as a primary antibody ...
-
bioRxiv - Microbiology 2023Quote: ... and a mouse anti-SARS-CoV-2 N monoclonal antibody (clone 1035111, R&D Systems, Cat# MAB10474-SP, 1:400) was used as a primary antibody ...